17,881 resources
By Version
By Realm
Start Prev Rows 13000 - 13200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
hl7.terminology | R5 | v3-EntityClassStateOrProvince | EntityClassStateOrProvince | active | 2014-03 | uv | tho | ||
hl7.fhir.us.davinci-vbpr | R4 | threshold-type | Threshold Type | trial-use | 1 | cqi | 2025-07 | us | fhir |
hl7.fhir.us.covid19library | R4 | covid19-pos-neg-vs | Positive, Negative value set | active | 2022-07 | us | sct | ||
hl7.fhir.uv.cardx-cied | R5 | cied-monitor-types-vs | CIED Monitor Types | trial-use | 2 | cic | 2025-07 | uv | fhir |
hl7.fhir.nz.cca | R4 | cancer-type-code | Cancer type | active | 2020-11 | nz | sct | ||
hl7.terminology | R5 | ex-payee-resource-type | ClaimPayeeResourceType | draft | fm | 2020-02 | uv | tho | |
hl7.terminology | R5 | plan-definition-type | PlanDefinitionType | active | 2 | cds | 2024-04 | uv | tho |
hl7.terminology | R5 | statistic-type | StatisticStatisticType | active | 5 | fhir | 2024-04 | uv | tho |
hl7.terminology | R5 | action-type | ActionType | active | 2 | cds | 2024-04 | uv | tho |
signal.core.r4 | R4 | address-type | AddressType | normative | 5 | fhir | 2019-10 | us | fhir |
hl7.fhir.uv.extensions | R5 | artifact-comment-type | Artifact comment type valueset | trial-use | 2 | cds | 2019-03 | uv | fhir |
nhsd.assets.stu3 | R3 | ValueSet-eRS-AttachmentType-1 | eRS Attachment Type | active | 2018-02 | ||||
NHSDigital.FHIR.STU3 | R3 | ValueSet-eRS-AttachmentStatus-1 | eRS Attachment Status | active | 2018-02 | ||||
hl7.terminology | R5 | v3-ContainerCap | ContainerCap | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | catalogType | CatalogType | active | sd | 2024-04 | uv | tho | |
hl7.fhir.uv.cmi | R4 | value-filter-comparator | Value Filter Comparator | active | 2021-08 | uv | fhir | ||
hl7.fhir.uv.extensions | R5 | value-filter-comparator | Value Filter Comparator | trial-use | 1 | cds | 2021-08 | uv | fhir |
hl7.fhir.uv.cardx-cied | R5 | 11073-10103-DeviceType | IEEE 11073-10103 Device Type | trial-use | 2 | cic | 2025-07 | uv | fhir |
hl7.terminology | R5 | v3-DocumentSectionType | DocumentSectionType | active | sd | 2014-03 | uv | tho loinc | |
hl7.fhir.fr.core | R4 | fr-core-vs-email-type | FR Core ValueSet Email type | informative | 0 | fhir | 2024-09 | fr | |
hl7.fhir.ca.baseline | R4 | encountertype | Encounter Type | draft | 2020-07 | ca | sct | ||
signal.core.r4 | R4 | us-core-encounter-type | US Core Encounter Type | active | 2022-09 | us | sct cpt | ||
hl7.fhir.us.mcode | R4 | mcode-cancer-disease-status-evidence-type-vs | Cancer Disease Status Evidence Type Value Set | active | 3 | cic | 2025-02 | us | sct |
hl7.fhir.uv.imaging-service-request-ig | R6 | imagingselection-referencetype | Imaging Selection Reference Type | draft | ii | 2025-03 | uv | dcm | |
hl7.fhir.uv.extensions.r4b | R4B | artifactassessment-information-type | Artifact Assessment Information Type | trial-use | 1 | cds | 2020-12 | uv | fhir |
hl7.terminology | R5 | library-type | LibraryType | active | 2 | cds | 2024-04 | uv | tho |
hl7.terminology | R5 | measure-type | MeasureType | active | 2 | cqi | 2024-04 | uv | tho |
hl7.fhir.uv.cow | R4 | order-notification-status-type | Order Notification Status Type | trial-use | 1 | oo | 2025-05 | uv | fhir |
hl7.fhir.us.core | R4 | us-core-provenance-participant-type | US Core Provenance Participant Type Codes | trial-use | 3 | cgp | 2022-09 | us | fhir tho |
hl7.terminology | R5 | provenance-agent-type | Provenance participant type | active | 1 | fm | 2024-06 | uv | tho |
hl7.terminology | R5 | resource-type-link | PayeeResourceType | draft | fm | 2020-02 | uv | tho | |
hl7.terminology | R5 | v3-ActInformationAccessCode | ActInformationAccessCode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | measure-population | MeasurePopulationType | active | 4 | cqi | 2024-04 | uv | tho |
hl7.terminology | R5 | audit-event-outcome | Audit Event Outcome | active | 3 | sec | 2010-08 | uv | tho |
hl7.terminology | R5 | audit-source-type | Audit Event Source Type | active | 3 | sec | 2010-08 | uv | tho |
hl7.terminology | R5 | v3-ActBillingArrangementCode | ActBillingArrangementCode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | published-in-type | Published In Type | trial-use | 1 | cds | 2025-01 | uv | tho |
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-brachytherapy-device-type-vs | Brachytherapy Device Type Value Set | active | cgp | 2025-02 | us | sct | |
hl7.fhir.nz.cca | R4 | sact-regimen-code | Regimen type code | active | 2020-11 | nz | |||
signal.core.r4 | R4 | document-relationship-type | DocumentRelationshipType | trial-use | 3 | sd | 2019-10 | us | fhir |
hl7.fhir.uv.fhir-for-fair | R4B | related-artifact-type | RelatedArtifactType [ValueSet] | active | 2024-01 | uv | fhir | ||
hl7.fhir.uv.cardx-cied | R5 | 11073-10103-SessionType | IEEE 11073-10103 Session Type | trial-use | 2 | cic | 2025-07 | uv | fhir |
hl7.fhir.us.breastcancer | R3 | oncology-BreastSpecimenTypeVS | BC BreastSpecimenTypeVS ValueSet | draft | 2018-08 | us | fhir sct | ||
hl7.terminology | R5 | study-type | StatisticStudyType | draft | 0 | cds | 2020-02 | uv | tho |
hl7.fhir.us.pq-cmc-fda | R5 | cmc-product-name-types-vs | Product Name Types Terminology | trial-use | 2 | brr | 2025-07 | us | ncit |
hl7.fhir.uv.extensions.r4b | R4B | device-specification-type | Device Specification Type | draft | 1 | oo | uv | iso | |
hl7.fhir.uv.extensions.r3 | R3 | performer-function | Performer Function Codes | draft | fhir | 2023-03 | uv | tho | |
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.69.17 | Obligation or Prohibition Instruction Type | active | 2018-01 | us | sct | ||
hl7.terminology | R5 | v3-xEncounterAdmissionUrgency | x_EncounterAdmissionUrgency | active | 2014-03 | uv | tho | ||
Test.Training | R3 | CareConnect-NameUse-1 | NameUse | draft | 0 | fhir | 2017-04 | fhir | |
NHSDigital.FHIR.STU3 | R3 | CareConnect-NameUse-1 | NameUse | draft | 0 | fhir | 2017-04 | fhir | |
ca.on.oh-olis | R4 | name-use | NameUse | normative | 5 | fhir | 2019-10 | fhir | |
nhsd.assets.stu3 | R3 | EMS-AddressUse-1 | AddressUse | draft | 0 | fhir | 2017-04 | fhir | |
signal.core.r4 | R4 | address-use | AddressUse | normative | 5 | fhir | 2019-10 | us | fhir |
hl7.fhir.fr.core | R4 | fr-core-vs-identity-method-collection | FR Core ValueSet Identity method collection | active | 2024-09 | fr | internal | ||
hl7.fhir.fr.core | R4 | fr-core-vs-mode-validation-identity | FR Core ValueSet Mode validation identity | active | 2024-09 | fr | internal | ||
hl7.fhir.uv.extensions | R5 | parent-relationship-codes | Parent Relationship Codes | trial-use | 3 | pc | 2025-08 | uv | tho |
hl7.fhir.uv.extensions | R5 | sibling-relationship-codes | Sibling Relationship Codes | trial-use | 3 | pc | 2025-08 | uv | tho |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2304 | Organisms (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain) | active | 2024-06 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2359 | Organisms (Tests by Microscopic Observation in Unspecified Tissue) | active | 2024-06 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.900 | Organisms (Tests by Microscopic Observation) | active | 2024-06 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2303 | Organisms (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain) | active | 2024-06 | us | loinc | ||
signal.core.r4 | R4 | formatcodes | DocumentReference Format Code Set | active | sd | 2019-10 | us | ihe | |
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.90 | D(Rh) Sensitized | active | 2024-06 | us | sct | ||
hl7.terminology | R5 | immunization-program-eligibility | Immunization Program Eligibility | active | 1 | pher | 2024-04 | uv | tho |
hl7.terminology | R5 | immunization-subpotent-reason | Immunization Subpotent Reason | active | 1 | pher | 2024-04 | uv | tho |
hl7.terminology | R5 | immunization-evaluation-dose-status-reason | Immunization Evaluation Dose Status Reason codes | active | 1 | pher | 2024-04 | uv | tho |
hl7.terminology | R5 | immunization-funding-source | Immunization Funding Source | active | 1 | pher | 2024-04 | uv | tho |
hl7.terminology | R5 | immunization-recommendation-status | Immunization Recommendation Status Codes | active | 1 | pher | 2024-04 | uv | tho |
hl7.terminology | R5 | immunization-evaluation-dose-status | Immunization Evaluation Dose Status codes | active | 1 | pher | 2024-04 | uv | tho |
hl7.fhir.us.central-cancer-registry-reporting | R4 | cancer-core-reportability-codes | Cancer Core Reportability Codes | trial-use | 2 | pher | 2021-11 | us | sct icd |
hl7.fhir.us.bfdr | R4 | ValueSet-newborn-congenital-anomalies | Newborn Congenital Anomalies | draft | pher | 2025-08 | us | sct tho | |
hl7.terminology | R5 | allergyintolerance-verification | AllergyIntolerance Verification Status | active | 3 | pc | 2024-04 | uv | tho |
hl7.terminology | R5 | condition-ver-status | ConditionVerificationStatus | active | 3 | pc | 2024-04 | uv | tho |
signal.core.r4 | R4 | condition-ver-status | ConditionVerificationStatus | trial-use | 3 | pc | 2019-10 | us | tho |
hl7.fhir.uv.cmi | R4 | cql-version | CQL Version | active | 2021-09 | uv | fhir | ||
hl7.terminology | R5 | artifact-version-policy | Artifact Version Policy | trial-use | 1 | cds | 2024-02 | uv | tho |
hl7.terminology | R5 | v3-EntityRisk | EntityRisk | active | 2014-03 | uv | tho | ||
signal.core.r4 | R4 | composition-status | CompositionStatus | trial-use | 3 | sd | 2019-10 | us | fhir |
fhir.cdc.opioid-cds-r4 | R4 | therapies-indicating-end-of-life-care | Therapies indicating end of life care | active | 2023-05 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.233 | Digital Access Goals | active | 2024-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.225 | Digital Literacy Goals | active | 2024-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.65 | Elder Abuse Goals | active | 2022-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.30 | Financial Insecurity Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.16 | Food Insecurity Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.121 | Health Insurance Coverage Status Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.117 | Health Literacy Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.159 | Homelessness Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.161 | Housing Instability Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.50 | Inadequate Housing Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.257 | Incarceration Status Goals | active | 2024-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.100 | Intimate Partner Violence Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.266 | Language Access Goals | active | 2024-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.55 | Less Than High School Education Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.37 | Material Hardship Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.120 | Medical Cost Burden Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.89 | Social Connection Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.86 | Stress Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.163 | Transportation Insecurity Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.70 | Unemployment Goals | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.245 | Utility Insecurity Goals | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.214 | Veteran Status Goals | active | 2023-07 | us | vsac | ||
hl7.terminology | R5 | v3-ComplianceDetectedIssueCode | ComplianceDetectedIssueCode | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.31 | HER2 Positive | active | 2023-09 | us | sct | ||
hl7.terminology | R5 | v3-ActMoodCompletionTrack | ActMoodCompletionTrack | active | 2014-03 | uv | tho | ||
hl7.fhir.us.davinci-pas | R4 | AHANUBCRevenueCodes | AHA NUBC Revenue Value Set | trial-use | 3 | fm | 2025-07 | us | |
hl7.terminology | R5 | v3-DischargeDisposition | Discharge Disposition | active | 2024-09 | uv | |||
hl7.fhir.us.consent-management | R4 | LOINCConsentDocumentTypes | LOINC Consent Document Types | trial-use | 1 | cbcc | 2025-08 | us | loinc |
hl7.fhir.us.davinci-pct | R4 | PCTGFEFrequencyVS | PCT GFE Frequency Code Value Set | trial-use | fm | 2025-08 | us | fhir | |
hl7.terminology | R5 | v3-TableCellHorizontalAlign | TableCellHorizontalAlign | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-TableCellScope | TableCellScope | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-TableCellVerticalAlign | TableCellVerticalAlign | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-TableFrame | TableFrame | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-TableRules | TableRules | active | 2014-03 | uv | tho | ||
hl7.fhir.us.covid19library | R4 | det-notdet-equivocal-invalid-vs | Detected, Not-detected, Equivocal, Invalid value set | active | 2022-07 | us | fhir sct | ||
hl7.terminology | R5 | v3-ActStatusObsolete | ActStatusObsolete | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActStatusNullified | ActStatusNullified | active | 2014-03 | uv | tho | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-foph-patient-name-representation | CH ELM FOPH Patient Name Representation | active | 2025-08 | ch | internal | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-avidity | CH ELM Interpretation Codes AVIDITY | active | 2025-08 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-pos-neg | CH ELM Interpretation Codes Positive and Negative | active | 2025-08 | ch | tho | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-pos | CH ELM Interpretation Codes Positive | active | 2025-08 | ch | tho | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-res-sus | CH ELM Interpretation Codes Resistant and Susceptible | active | 2025-08 | ch | tho | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-res | CH ELM Interpretation Codes Resistant | active | 2025-08 | ch | tho | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-sero | CH ELM Interpretation Codes SERO | active | 2025-08 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-titer | CH ELM Interpretation Codes TITER | active | 2025-08 | ch | tho | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-laboratory-observation-complete | CH ELM Results Laboratory Observation Complete | active | 2025-08 | ch | sct loinc | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-laboratory-observation-susc | CH ELM Results Laboratory Observation Susceptibility | active | 2025-08 | ch | loinc | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-laboratory-observation-geno | CH ELM Results Laboratory Observation Genotyping | active | 2025-08 | ch | loinc | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-status | CH ELM Status | active | 2025-08 | ch | fhir | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-lab-study-types | CH ELM Lab Study Types | active | 2025-08 | ch | sct loinc | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-laboratory-observation | CH ELM Results Laboratory Observation | active | 2025-08 | ch | sct loinc | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-coded-values-laboratory | CH ELM Results Coded Values Laboratory | active | 2025-08 | ch | sct | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-expecting-organism-specification | CH ELM Expecting Organism Specification | active | 2025-08 | ch | loinc | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-expecting-specimen-specification | CH ELM Expecting Specimen Specification | active | 2025-08 | ch | loinc | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-observation-profile-vs | CH ELM Observation Profile Vs | active | 2025-08 | ch | internal | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-completion-vs | CH ELM Results Completion Vs | active | 2025-08 | ch | internal | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-results-component-vs | CH ELM Results Component Vs | active | 2025-08 | ch | internal | ||
ch.fhir.ig.ch-elm | R4 | ch-elm-interpretation-codes-vs | CH ELM Interpretation Codes Vs | active | 2025-08 | ch | internal | ||
hl7.fhir.us.dental-data-exchange | R4 | dental-anatomy | Dental Anatomy | draft | 2025-04 | us | fhir | ||
hl7.fhir.uv.extensions | R5 | object-lifecycle-events | ObjectLifecycleEvents | trial-use | 3 | sec | 2017-02 | uv | tho |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.29 | HER2 Positive | active | 2023-09 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.30 | HER2 Positive | active | 2023-12 | us | ncit | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.99 | Nutrition Diagnosis SNOMED CT (2) | active | 2024-05 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1267.24 | Specimen Condition SCT | active | 2024-11 | us | sct | ||
hl7.fhir.uv.saner | R4 | MeasureRateAggregationValues | Measure Rate Aggregation Value Set | active | pher | 2024-05 | uv | fhir | |
hl7.fhir.uv.saner | R4 | EventContext | Event Context | active | pher | 2024-05 | uv | sct | |
hl7.fhir.uv.saner | R4 | SARSCoV2Labs | SARS CoV2 Labs | active | pher | 2020-04 | uv | loinc | |
hl7.fhir.uv.saner | R4 | SARSCoV2GeneticLabs | SARSCoV2 Genetic Labs | draft | pher | 2024-05 | uv | loinc | |
hl7.fhir.uv.saner | R4 | Remdesivir | Remdesivir | active | pher | 2024-05 | uv | sct rx | |
hl7.fhir.uv.saner | R4 | COVID19Organism | COVID-19 Organism | active | pher | 2020-07 | uv | sct | |
hl7.fhir.uv.saner | R4 | SuspectedCOVID19Diagnoses | Suspected COVID19 Diagnoses | draft | pher | 2020-04 | uv | sct icd | |
hl7.fhir.uv.saner | R4 | PatientsOnVentilator | Observations for Patients on a Ventilator | active | pher | 2024-05 | uv | loinc | |
hl7.fhir.uv.saner | R4 | COVID19Exposures | COVID-19 Exposures | active | pher | 2020-06 | uv | sct | |
hl7.fhir.uv.saner | R4 | COVID19DXICD10 | COVID-19 ICD-10 | active | pher | 2020-05 | uv | icd | |
hl7.fhir.uv.saner | R4 | COVID19DXSNOMED | COVID-19 SNOMED | draft | pher | 2020-08 | uv | sct | |
hl7.fhir.uv.saner | R4 | COVID19Antibody | COVID-19 Antibody | active | pher | 2020-04 | uv | sct | |
hl7.fhir.uv.saner | R4 | HealthcareServiceLocation | Healthcare Service Location | active | pher | 2019-08 | uv | cdc | |
hl7.eu.fhir.oah | R4 | macrophytes-indicator-code-oah-vs | OAH Macrophytes Indicator Codes | draft | 2025-08 | eu | internal | ||
hl7.eu.fhir.oah | R4 | macrophytes-indicator-value-oah-vs | OAH Macrophytes Indicator Values | draft | 2025-08 | eu | internal | ||
hl7.eu.fhir.oah | R4 | riparian-vegetation-code-oah-vs | OAH Riparian Vegetation Indicator Codes | draft | 2025-08 | eu | internal | ||
hl7.eu.fhir.oah | R4 | riparian-vegetation-value-oah-vs | OAH Riparian Vegetation Indicator Values | draft | 2025-08 | eu | internal | ||
hl7.eu.fhir.oah | R4 | specimen-type-oah-vs | OAH Specimen Type | draft | 2025-08 | eu | sct | ||
hl7.eu.fhir.oah | R4 | temporarySystem-oah-eu | OAH Indicators | draft | 2025-08 | eu | internal | ||
hl7.eu.fhir.oah | R4 | nonnative-macrophytes-indicator-code-oah-vs | OAH Macrophytes Indicator Codes (Non-Native) | draft | 2025-08 | eu | internal | ||
hl7.eu.fhir.oah | R4 | observation-type-with-component-oah-vs | OAH Observation Type with Components | draft | 2025-08 | eu | internal | ||
hl7.fhir.uv.saner | R4 | BedLocationOperationalStatus | Bed Location Operational Status | active | pher | 2024-05 | uv | tho | |
HIE2.packages | R4 | result-coded-value-laboratory-gps-uv-ips | Results Coded Values Laboratory (GPS) - IPS | active | 2022-01 | uv | fhir | ||
nhsd.assets.stu3 | R3 | ValueSet-ITK-AccessibleInformation-1 | ITK Accessible Information | draft | 2017-10 | sct | |||
nhsd.assets.stu3 | R3 | ValueSet-ITK-AllergyFlagCode-1 | Allergy Flag Code | draft | 2017-08 | sct | |||
nhsd.assets.stu3 | R3 | ValueSet-ITK-Mobility-1 | ITK Mobility | draft | 2017-10 | sct | |||
hl7.fhir.us.mihr | R4 | PregnancyProcedureDelivery-CPT | Pregnancy Procedure Delivery CPT | draft | 2023-03 | us | cpt | ||
hl7.fhir.us.dental-data-exchange | R4 | dental-reason-for-referral | DentalReasonForReferral | draft | 2025-04 | us | sct icd | ||
hl7.eu.fhir.idea4rc | R4 | radiotherapy-site-laterality-qualifier-eu-i4rc | Radiotherapy Site Laterality Qualifier | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | radiotherapy-site-eu-i4rc | Radiotherapy Sites | active | 2025-07 | eu | internal | ||
hl7.eu.fhir.idea4rc | R4 | surgery-location-qualifier-eu-i4rc | Surgery Location Qualifier | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | surgery-site-laterality-qualifier-eu-i4rc | Surgery Site Laterality Qualifier | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | surgery-site-eu-i4rc | Surgery Sites | active | 2025-07 | eu | internal | ||
hl7.fhir.us.dental-data-exchange | R4 | tooth-identification-valueset | Tooth Identification ValueSet | draft | 2025-04 | us | sct | ||
hl7.fhir.us.dental-data-exchange | R4 | oral-cavity-area | Oral Cavity Area | draft | 2025-04 | us | sct | ||
hl7.fhir.be.medication | R4 | BeRouteOfAdministrationVS | Route of Administration ValueSet | active | 2025-07 | be | sct | ||
hl7.eu.fhir.idea4rc | R4 | imaging-body-sites-i4rc | Immaging Body sites | draft | 2025-07 | eu | internal | ||
hl7.eu.fhir.idea4rc | R4 | imaging-clinical-stage-i4rc | Immaging Clinical Stage | draft | 2025-07 | eu | internal | ||
hl7.eu.fhir.idea4rc | R4 | imaging-clinical-stage-metastasis-i4rc | Immaging Clinical Stage Metastasis | draft | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | imaging-clinical-stage-neck-i4rc | Immaging Clinical Stage Neck | draft | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | imaging-clinical-stage-primary-site-i4rc | Immaging Clinical Stage Primary Site | draft | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | genetic-test-expression-i4rc | Genetic test expression | draft | 2025-07 | eu | |||
fhir.r4.nhsengland.stu1 | R4 | England-Consent-Type | England Consent Type | draft | 2025-07 | us | |||
fhir.astp.bhp | R4 | bh-funding-types | Behavioral Health Program Funding Types | draft | 2025-07 | us | internal | ||
fhir.astp.bhp | R4 | mental-health-clinical-note-types | Mental Health Clinical Note Types | draft | 2025-07 | us | loinc | ||
fhir.r4.nhsengland.stu1 | R4 | England-OrganisationRole | England Organisation Role | active | 2023-12 | us | |||
fhir.r4.nhsengland.stu1 | R4 | England-TypedDateTime | England Typed Date Time | active | 2023-12 | us | |||
fhir.r4.nhsengland.stu1 | R4 | England-FlagRemovalReason | England Flag Removal Reason | active | 2023-11 | us | |||
hl7.eu.fhir.idea4rc | R4 | regimen-eu-i4rc | Regimen | draft | 2025-07 | eu | internal | ||
fhir.r4.nhsengland.programme | R4 | England-FlagCategoryPatient | England Flag Category Patient | draft | 2025-03 | us | |||
hl7.fhir.us.cancer-reporting | R4 | cap-ecc-answer-codes | CAP eCC Answer Codes | trial-use | oo | 2025-07 | us | fhir | |
hl7.fhir.us.cancer-reporting | R4 | cap-ecc-form-codes | CAP eCC Form Codes | trial-use | oo | 2025-07 | us | fhir | |
hl7.fhir.us.cancer-reporting | R4 | us-pathology-provider-types | US Pathology Provider Types | trial-use | oo | 2025-07 | us | tho | |
hl7.fhir.us.cancer-reporting | R4 | cap-ecc-question-codes | CAP eCC Question Codes | trial-use | oo | 2025-07 | us | fhir | |
hl7.fhir.us.cancer-reporting | R4 | cap-ecc-section-codes | CAP eCC Section Codes | trial-use | oo | 2025-07 | us | fhir | |
hl7.fhir.us.cancer-reporting | R4 | us-pathology-form-category-codes | US Pathology Form Category Codes | trial-use | oo | 2025-07 | us | fhir |